Sfoglia per Autore
Feasibility of cord blood stem cell manipulation with high-energy shock waves: an in vitro and in vivo study
2005-01-01 BERGER M; FRAIRIA R; PIACIBELLO W; SANAVIO F; PALMERO A; VENTURI C; PIGNOCHINO Y; BERTA L; MADON E; AGLIETTA M; FAGIOLI F
Tumor cell purging by ex vivo expansion of hemopoietic stem cells from breast cancer patients combined with targeting ErbB receptors
2006-01-01 F. LEONE; G. CAVALLONI; M. GUNETTI; Y. PIGNOCHINO; W. PIACIBELLO; M. AGLIETTA
Serial transplantations in nonobese diabetic/severe combined immunodeficiency mice of transduced human CD34+ cord blood cells: efficient oncoretroviral gene transfer and ex vivo expansion under serum-free conditions
2006-01-01 GAMMAITONI L; LUCCHI S; BRUNO S; TESIO M; GUNETTI M; PIGNOCHINO Y; MIGLIARDI G; LAZZARI L; AGLIETTA M; REBULLA P; PIACIBELLO W
Somatic mutations of epidermal growth factor receptor in bile duct and gallbladder carcinoma
2006-01-01 F. LEONE; G. CAVALLONI; Y. PIGNOCHINO; I. SAROTTO; R. FERRARIS; V. PIACIBELLO; T. VENESIO; L. CAPUSSOTTI; M. RISIO; M. AGLIETTA
Multilineage engraftment of refrozen cord blood hematopoietic progenitors in NOD/SCID mice
2006-01-01 TIMEUS F; CRESCENZIO N; SANAVIO F; FAZIO L; DORIA A; FOGLIA L; PIGNOCHINO Y; BERGER M; PIACIBELLO W; MADON E; CORDERO DI MONTEZEMOLO L; FAGIOLI F
Targeting of epidermal growth factor receptor in patients affected by biliary tract carcinoma
2007-01-01 LEONE F; PIGNOCHINO Y; CAVALLONI G; AGLIETTA M
Sustained Long Term Engraftment and Transgene Expression of Peripheral Blood CD34+ Cells Transduced with Third-Generation Lentiviral Vectors
2008-01-01 TESIO M; GAMMAITONI L; GUNETTI M; LEUCI V; PIGNOCHINO Y; JORDANEY N; CAPELLERO S; CAMMARATA C; CAIONE L; MIGLIARETTI G; FAGIOLI F; TABILIO A; AGLIETTA M; PIACIBELLO W
Granulocyte-colony stimulating factor upregulates ErbB2 expression on breast cancer cell lines and converts primary resistance to trastuzumab
2008-01-01 Cavalloni G; Sarotto I; Pignochino Y; Gammaitoni L; Migliardi G; Sgro L; Piacibello W; Risio M; Aglietta M; Leone F
Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways
2009-01-01 Pignochino Y; Grignani G; Cavalloni G; Motta M; Tapparo Ml; Bruno S; Bottos A; Gammaitoni L; Migliardi G; Camussi G; Aberghini M; Torchio B; Ferrari S; Bussolino F; Fagioli F; Picci P; Aglietta M
Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas
2010-01-01 Pignochino Y; Sarotto I; Peraldo-Neia C; Penachioni JY; Cavalloni G; Migliardi G; Casorzo L; Chiorino G; Risio M; Bardelli A; Aglietta M; Leone F.
Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer.
2011-01-01 Peraldo-Neia C; Migliardi G; Mello-Grand M; Montemurro F; Segir R; Pignochino Y; Cavalloni G; Torchio B; Mosso L; Chiorino G; Aglietta M.
Abstract LB-366: Everolimus (EV) potentiates Sorafenib (SOR)activity in osteosarcoma (OS) preclinical models: a combination targeting the crosstalk between ERK1/2 and mTORC1/2 signaling pathways
2012-01-01 Pignochino, Y.; Dell'Aglio, C.; Basirico, M.; Capozzi, F.; Tarraran, L.; Soster, M.; Marchio, S.; Bruno, S.; Gammaitoni, L.; Sangiolo, D.; D'ambrosio, L.; Picci, P.; Aglietta, M.; Grignani, G.
Ex Vivo Allogeneic Stimulation Significantly Improves Expansion of Cytokine-Induced Killer Cells Without Increasing Their Alloreactivity Across HLA Barriers.
2012-01-01 Todorovic M; Mesiano G; Gammaitoni L; Leuci V; Giraudo Diego L; Cammarata C; Jordaney N; Carnevale-Schianca F; Gallo S; Fagioli F; Piacibello W; Elia AR; Pignochino Y; Dell'aglio C; Grignani G; Cignetti A; Aglietta M; Sangiolo D.
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study.
2012-01-01 Grignani G; Palmerini E; Dileo P; Asaftei SD; D'Ambrosio L; Pignochino Y; Mercuri M; Picci P; Fagioli F; Casali PG; Ferrari S; Aglietta M.
Generation and characterization of two primary cultures of osteosarcoma and Ewing’s sarcoma
2013-01-01 Signorino Elena, Sanavio Fiorella, Pittana Laura, Muraro Michela, Castiglia Sara, Ferrero Ivana, Pignochino Ymera, Basificò M, Aglietta Massimo, Fagioli Franca
Preclinical models of tumour-specific cytotoxic T lymphocytes in sarcoma patients
2013-01-01 Signorino Elena, Sanavio Fiorella, Pittana Laura, Muraro Michela, Ferrero Ivana, Pignochino Ymera, Basificò M, Aglietta Massimo, Fagioli Franca
Prolonged disease stability with trabectedin in a heavily pretreated elderly patient with metastatic leiomyosarcoma of the thigh and renal failure: a case report and review of the literature.
2013-01-01 Galizia D; Palesandro E; Nuzzo AM; Pignochino Y; Aliberti S; Aglietta M; Grignani G.
Effective Activity of Cytokine Induced Killer Cells against Autologous Metastatic Melanoma including Cells with Stemness Features.
2013-01-01 Gammaitoni L;Giraudo L;Leuci V;Todorovic M;Mesiano G;Picciotto F;Pisacane A;Zaccagna A;Volpe MG;Gallo S;Caravelli D;Giacone E;Venesio T;Balsamo A;Pignochino Y;Grignani G;Carnevale-Schianca F;Aglietta M;Sangiolo D
The Combination of Sorafenib and Everolimus abrogates mTORC-1 and mTORC2 up-regulation in preclinical models of Osteosarcoma.
2013-01-01 Pignochino Y;Dell'aglio C;Basirico M;Capozzi F;Soster M;Marchio S;Bruno S;Gammaitoni L;Sangiolo D;Torchiaro E;D'Ambrosio L;Fagioli F;Ferrari S;Alberghini M;Picci P;Aglietta M;Grignani G
Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas.
2014-01-01 Sangiolo D; Mesiano G; Gammaitoni L; Leuci V; Todorovic M; Giraudo L; Cammarata C; Dell'aglio C; D'Ambrosio L; Pisacane A; Sarotto I; Miano S; Ferrero I; Carnevale-Schianca F; Pignochino Y; Sassi F; Bertotti A; Piacibello W; Fagioli F; Aglietta M; Grignani G.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Feasibility of cord blood stem cell manipulation with high-energy shock waves: an in vitro and in vivo study | 2005 | BERGER M; FRAIRIA R; PIACIBELLO W; SANAVIO F; PALMERO A; VENTURI C; PIGNOCHINO Y; BERTA L; MADON E; AGLIETTA M; FAGIOLI F | |
Tumor cell purging by ex vivo expansion of hemopoietic stem cells from breast cancer patients combined with targeting ErbB receptors | 2006 | F. LEONE; G. CAVALLONI; M. GUNETTI; Y. PIGNOCHINO; W. PIACIBELLO; M. AGLIETTA | |
Serial transplantations in nonobese diabetic/severe combined immunodeficiency mice of transduced human CD34+ cord blood cells: efficient oncoretroviral gene transfer and ex vivo expansion under serum-free conditions | 2006 | GAMMAITONI L; LUCCHI S; BRUNO S; TESIO M; GUNETTI M; PIGNOCHINO Y; MIGLIARDI G; LAZZARI L; AGLIETTA M; REBULLA P; PIACIBELLO W | |
Somatic mutations of epidermal growth factor receptor in bile duct and gallbladder carcinoma | 2006 | F. LEONE; G. CAVALLONI; Y. PIGNOCHINO; I. SAROTTO; R. FERRARIS; V. PIACIBELLO; T. VENESIO; L. CAPUSSOTTI; M. RISIO; M. AGLIETTA | |
Multilineage engraftment of refrozen cord blood hematopoietic progenitors in NOD/SCID mice | 2006 | TIMEUS F; CRESCENZIO N; SANAVIO F; FAZIO L; DORIA A; FOGLIA L; PIGNOCHINO Y; BERGER M; PIACIBELLO W; MADON E; CORDERO DI MONTEZEMOLO L; FAGIOLI F | |
Targeting of epidermal growth factor receptor in patients affected by biliary tract carcinoma | 2007 | LEONE F; PIGNOCHINO Y; CAVALLONI G; AGLIETTA M | |
Sustained Long Term Engraftment and Transgene Expression of Peripheral Blood CD34+ Cells Transduced with Third-Generation Lentiviral Vectors | 2008 | TESIO M; GAMMAITONI L; GUNETTI M; LEUCI V; PIGNOCHINO Y; JORDANEY N; CAPELLERO S; CAMMARATA C; CAIONE L; MIGLIARETTI G; FAGIOLI F; TABILIO A; AGLIETTA M; PIACIBELLO W | |
Granulocyte-colony stimulating factor upregulates ErbB2 expression on breast cancer cell lines and converts primary resistance to trastuzumab | 2008 | Cavalloni G; Sarotto I; Pignochino Y; Gammaitoni L; Migliardi G; Sgro L; Piacibello W; Risio M; Aglietta M; Leone F | |
Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways | 2009 | Pignochino Y; Grignani G; Cavalloni G; Motta M; Tapparo Ml; Bruno S; Bottos A; Gammaitoni L; Migliardi G; Camussi G; Aberghini M; Torchio B; Ferrari S; Bussolino F; Fagioli F; Picci P; Aglietta M | |
Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas | 2010 | Pignochino Y; Sarotto I; Peraldo-Neia C; Penachioni JY; Cavalloni G; Migliardi G; Casorzo L; Chiorino G; Risio M; Bardelli A; Aglietta M; Leone F. | |
Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer. | 2011 | Peraldo-Neia C; Migliardi G; Mello-Grand M; Montemurro F; Segir R; Pignochino Y; Cavalloni G; Torchio B; Mosso L; Chiorino G; Aglietta M. | |
Abstract LB-366: Everolimus (EV) potentiates Sorafenib (SOR)activity in osteosarcoma (OS) preclinical models: a combination targeting the crosstalk between ERK1/2 and mTORC1/2 signaling pathways | 2012 | Pignochino, Y.; Dell'Aglio, C.; Basirico, M.; Capozzi, F.; Tarraran, L.; Soster, M.; Marchio, S.; Bruno, S.; Gammaitoni, L.; Sangiolo, D.; D'ambrosio, L.; Picci, P.; Aglietta, M.; Grignani, G. | |
Ex Vivo Allogeneic Stimulation Significantly Improves Expansion of Cytokine-Induced Killer Cells Without Increasing Their Alloreactivity Across HLA Barriers. | 2012 | Todorovic M; Mesiano G; Gammaitoni L; Leuci V; Giraudo Diego L; Cammarata C; Jordaney N; Carnevale-Schianca F; Gallo S; Fagioli F; Piacibello W; Elia AR; Pignochino Y; Dell'aglio C; Grignani G; Cignetti A; Aglietta M; Sangiolo D. | |
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study. | 2012 | Grignani G; Palmerini E; Dileo P; Asaftei SD; D'Ambrosio L; Pignochino Y; Mercuri M; Picci P; Fagioli F; Casali PG; Ferrari S; Aglietta M. | |
Generation and characterization of two primary cultures of osteosarcoma and Ewing’s sarcoma | 2013 | Signorino Elena, Sanavio Fiorella, Pittana Laura, Muraro Michela, Castiglia Sara, Ferrero Ivana, Pignochino Ymera, Basificò M, Aglietta Massimo, Fagioli Franca | |
Preclinical models of tumour-specific cytotoxic T lymphocytes in sarcoma patients | 2013 | Signorino Elena, Sanavio Fiorella, Pittana Laura, Muraro Michela, Ferrero Ivana, Pignochino Ymera, Basificò M, Aglietta Massimo, Fagioli Franca | |
Prolonged disease stability with trabectedin in a heavily pretreated elderly patient with metastatic leiomyosarcoma of the thigh and renal failure: a case report and review of the literature. | 2013 | Galizia D; Palesandro E; Nuzzo AM; Pignochino Y; Aliberti S; Aglietta M; Grignani G. | |
Effective Activity of Cytokine Induced Killer Cells against Autologous Metastatic Melanoma including Cells with Stemness Features. | 2013 | Gammaitoni L;Giraudo L;Leuci V;Todorovic M;Mesiano G;Picciotto F;Pisacane A;Zaccagna A;Volpe MG;Gallo S;Caravelli D;Giacone E;Venesio T;Balsamo A;Pignochino Y;Grignani G;Carnevale-Schianca F;Aglietta M;Sangiolo D | |
The Combination of Sorafenib and Everolimus abrogates mTORC-1 and mTORC2 up-regulation in preclinical models of Osteosarcoma. | 2013 | Pignochino Y;Dell'aglio C;Basirico M;Capozzi F;Soster M;Marchio S;Bruno S;Gammaitoni L;Sangiolo D;Torchiaro E;D'Ambrosio L;Fagioli F;Ferrari S;Alberghini M;Picci P;Aglietta M;Grignani G | |
Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas. | 2014 | Sangiolo D; Mesiano G; Gammaitoni L; Leuci V; Todorovic M; Giraudo L; Cammarata C; Dell'aglio C; D'Ambrosio L; Pisacane A; Sarotto I; Miano S; Ferrero I; Carnevale-Schianca F; Pignochino Y; Sassi F; Bertotti A; Piacibello W; Fagioli F; Aglietta M; Grignani G. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile